Triple

T22457853
Position Surface form Disambiguated ID Type / Status
Subject ICH CTD E555159 entity
Predicate alsoKnownAs P39 FINISHED
Object Common Technical Document for the Registration of Pharmaceuticals for Human Use NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Common Technical Document for the Registration of Pharmaceuticals for Human Use | Statement: [ICH CTD, alsoKnownAs, Common Technical Document for the Registration of Pharmaceuticals for Human Use]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Common Technical Document for the Registration of Pharmaceuticals for Human Use
Context triple: [ICH CTD, alsoKnownAs, Common Technical Document for the Registration of Pharmaceuticals for Human Use]
  • A. Community code for medicinal products for human use
    The Community code for medicinal products for human use is a comprehensive European Union regulatory framework that harmonizes the authorization, supervision, and distribution of human medicines across EU member states.
  • B. Certificates of Suitability to the monographs of the European Pharmacopoeia
    Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
  • C. ICH Q11 Development and Manufacture of Drug Substances
    ICH Q11 Development and Manufacture of Drug Substances is an ICH guideline that provides principles and expectations for the development and manufacturing of chemical and biotechnological drug substances within a quality-by-design framework.
  • D. Commentar zur Pharmacopoea Germanica
    Commentar zur Pharmacopoea Germanica is a comprehensive pharmaceutical reference work by Hermann Hager that provides detailed explanations, annotations, and practical guidance related to the German pharmacopoeia.
  • E. Community register of orphan medicinal products
    The Community register of orphan medicinal products is the official European Union list of medicines designated for the diagnosis, prevention, or treatment of rare diseases, maintained under the EU’s orphan drug framework.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Common Technical Document for the Registration of Pharmaceuticals for Human Use
Target entity description: The Common Technical Document for the Registration of Pharmaceuticals for Human Use is an internationally harmonized format developed by the International Council for Harmonisation (ICH) for organizing and submitting data to regulatory authorities in support of new drug applications.
  • A. Community code for medicinal products for human use
    The Community code for medicinal products for human use is a comprehensive European Union regulatory framework that harmonizes the authorization, supervision, and distribution of human medicines across EU member states.
  • B. Certificates of Suitability to the monographs of the European Pharmacopoeia
    Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
  • C. ICH Q11 Development and Manufacture of Drug Substances
    ICH Q11 Development and Manufacture of Drug Substances is an ICH guideline that provides principles and expectations for the development and manufacturing of chemical and biotechnological drug substances within a quality-by-design framework.
  • D. Commentar zur Pharmacopoea Germanica
    Commentar zur Pharmacopoea Germanica is a comprehensive pharmaceutical reference work by Hermann Hager that provides detailed explanations, annotations, and practical guidance related to the German pharmacopoeia.
  • E. Community register of orphan medicinal products
    The Community register of orphan medicinal products is the official European Union list of medicines designated for the diagnosis, prevention, or treatment of rare diseases, maintained under the EU’s orphan drug framework.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e51fdec8190adfdf9f8a6362221 completed April 16, 2026, 5:37 p.m.
NER Named-entity recognition batch_69f15b7d00208190955a70e2c22d25a4 completed April 29, 2026, 1:14 a.m.
Created at: April 16, 2026, 8:48 p.m.